---
title: "No association found between BKPyV LTAg/VP1 proteins and skin GvHD after alloSCT"
id: "medrxiv-7-no-evidence-of-an-association-between-graft-versus-host-disease-and-bk"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-7-no-evidence-of-an-association-between-graft-versus-host-disease-and-bk"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1?rss=1"
published_at: "2026-11-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# No association found between BKPyV LTAg/VP1 proteins and skin GvHD after alloSCT
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-7-no-evidence-of-an-association-between-graft-versus-host-disease-and-bk
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1?rss=1)
- **Published At:** 2026-11-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators conducted an immunohistochemical (IHC) pilot study in adults who underwent **allogeneic stem cell transplantation (alloSCT)** and experienced **BK polyomavirus (BKPyV)** reactivation and skin graft-versus-host disease (GvHD). - The study was prospectively registered in the German Clinical Trials Register (DRKS00039127); the full protocol is available via the registry link. - Patient sampling included two groups: seven patients identified during an inpatient prospective trial for urological complications who developed acute skin GvHD, and five long-term survivors (more than five years post-alloSCT) with chronic skin GvHD. - The most common transplant indication was acute myeloid leukemia (n=7), with Non-Hodgkin lymphoma represented (n=2); the source did not report additional demographic breakdowns. - The primary laboratory endpoint was detection of BKPyV viral proteins—**LTAg** and **VP1**—by IHC on skin samples. - Data indicated that IHC was negative for both LTAg and VP1 across all examined patients, encompassing acute and chronic skin GvHD cases. - Because both viral proteins were negative in IHC, the authors reported that no further molecular investigations were performed. - The authors cautioned interpretation due to the pilot nature of the investigation and stated the results should be treated with care; the source did not provide power calculations or detailed methods beyond registration and protocol availability. - All study data are reportedly available on reasonable request to the authors; ethical approval from the University Medical Center Greifswald (BB 264/25) was obtained prior to study start, per the source.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=yNZ552TmprDuSrLHJwEKbJcsHqpYTQvU4dCuJO_5pNk-1794998475.9256766-1.2.1.1-MOYaG.SLdWu8wBEeOtQKKv_iWsO3vvO68gajc_95fl6xR6ty6wm6oHvw5wfFKqwR) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # No evidence of an association between graft-versus-host disease and BK polyomavirus viral proteins LTAg and VP1 Shabnan Asadikomeleh, Thomas Neumann, William Krueger, Silvia Ribback, Laila Schneidewind doi: https://doi.org/10.64898/2026.11.17.26368216 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Shabnan Asadikomeleh University of Greifswald * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Shabnan%2BAsadikomeleh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Asadikomeleh%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AShabnan%2BAsadikomeleh%2B) Thomas Neumann University of Greifswald * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Thomas%2BNeumann%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Neumann%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AThomas%2BNeumann%2B) William Krueger University of Greifswald * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=William%2BKrueger%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Krueger%20W&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AWilliam%2BKrueger%2B) Silvia Ribback University of Greifswald * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Silvia%2BRibback%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ribback%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASilvia%2BRibback%2B) Laila Schneidewind University of Greifswald * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Laila%2BSchneidewind%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Schneidewind%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALaila%2BSchneidewind%2B) * For correspondence: laila.schneidewind@uni-greifswald.de * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1347461/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1347461/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1347461/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1347461/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1347461/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Introduction: This is an immunohistochemical (IHC) pilot study of adult patients who underwent allogeneic stem cell transplantation (alloSCT) for hematological disease and had BKPyV reactivation (BKPyV viruria) as well as graft-versus-host-disease (GvHD) to investigate, if there is an association between these two diseases. Methods: The study was prospectively registered at the German Clinical Trials Register (https://drks.de/search/en/trial/DRKS00039127/details). The full protocol is available with this link. Results: Seven (58.3%) of the identified patients were treated in our prospective clinical trial regarding urological complications in alloSCT. All of them had BKPyV viruria during inpatient treatment for the transplantation and developed acute GvHD of the skin. Five (41.7%) of the patients were recruited in our prospective study of long-term survivors (more than five years) of alloSCT. All of them had BKPyV viruria as well as chronic GvHD of the skin at time of their examination. Acute myeloid leukemia was the most frequent underlying indication for alloSCT (n=7; 58.3%), followed by Non-Hodgkin-Lymphoma (NHL; n=2; 16,7%). Interestingly, IHC was negative for LTAg as well as VP1 in all patients. Therefore, it must also be stated that both virus proteins were negative in IHC for acute as well as chronic GvHD of the skin. Consequently, no further molecular investigations were realized. Conclusion: There is no evidence for an association between the viral proteins LTAg and VP1 of BKPyV and skin GvHD in immunohistochemistry. Due to the pilot character of our investigation, the results should be interpreted with great caution. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial DRKS00039127 ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Before starting the study, we obtained the approval of the local ethics review board at the University Medical Center Greifswald (BB 264/25 from December 21, 2025). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.15.26368155v1 "Multidrug-Resistant Tuberculosis Rates Among High-Risk Populations in Brazil: An Analysis from 2001 to 2021")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.15.26368163v1 "Frequency and antibiotic susceptibility of urinary Klebsiella in Lahore") Posted November 17, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/17/2026.11.17.26368216.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.17.26368216v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/17/2026.11.17.26368216.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) No evidence of an association between graft-versus-host disease and BK polyomavirus viral proteins LTAg and VP1 Shabnan Asadikomeleh, Thomas Neumann, William Krueger, Silvia Ribback, Laila Schneidewind medRxiv 2026.11.17.26368216; doi: https://doi.org/10.64898/2026.11.17.26368216 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368216v1%26text%3DNo%2520evidence%2520of%2520an%2520association%2520between%2520graft-versus-host%2520disease%2520and%2520BK%2520polyomavirus%2520viral%2520proteins%2520LTAg%2520and%2520VP1 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368216v1%26t%3DNo%2520evidence%2520of%2520an%2520association%2520between%2520graft-versus-host%2520disease%2520and%2520BK%2520polyomavirus%2520viral%2520proteins%2520LTAg%2520and%2520VP1 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368216v1%26title%3DNo%2520evidence%2520of%2520an%2520association%2520between%2520graft-versus-host%2520disease%2520and%2520BK%2520polyomavirus%2520viral%2520proteins%2520LTAg%2520and%2520VP1%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368216v1%26title%3DNo%2520evidence%2520of%2520an%2520association%2520between%2520graft-versus-host%2520disease%2520and%2520BK%2520polyomavirus%2520viral%2520proteins%2520LTAg%2520and%2520VP1 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.17.26368216) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.17.26368216v1&count=horizontal&via=&text=No%20evidence%20of%20an%20association%20between%20graft-versus-host%20disease%20and%20BK%20polyomavirus%20viral%20proteins%20LTAg%20and%20VP1&counturl=www.medrxiv.org/content/10.64898/2026.11.17.26368216v1 "Tweet This") ## Subject Area * [Infectious Diseases (except HIV/AIDS) ](https://www.medrxiv.org/collection/infectious_diseases) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (925) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5047) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (431) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1702) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16326) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1247) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7313) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (758) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1100) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5334) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1480) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1845) * [Hematology](https://www.medrxiv.org/collection/hematology) (601) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1387) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16526) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1206) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (702) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (755) * [Neurology](https://www.medrxiv.org/collection/neurology) (7647) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1139) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1303) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1045) * [Oncology](https://www.medrxiv.org/collection/oncology) (3760) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1102) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (413) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (471) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (506) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (144) * [Pathology](https://www.medrxiv.org/collection/pathology) (724) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1872) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (758) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (789) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6170) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10036) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2550) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1533) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1277) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (664) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (812) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (601) * [Surgery](https://www.medrxiv.org/collection/surgery) (807) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (320) * [Urology](https://www.medrxiv.org/collection/urology) (309) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related
## Related Clinical Research

- [Obesity-associated inflammation and cancer: mechanisms linking adipose immune changes to tumor risk](https://medichelpline.com/clinical-feed/frontiers-in-immunology-6-obesity-associated-inflammation-and-cancer-molecular-mechanisms-evidence-gaps.md)
- [Case report: ADMIO type 1 linked to de novo STAT3 gain-of-function mutation](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-a-case-report-of-admio-type-1-caused-by-a-de-novo-stat3-gain-of-function.md)
- [Heidi Overton FDA Nomination Withdrawn; Merck Stops Nemtabrutinib Program](https://medichelpline.com/clinical-feed/stat-news-2-stat-pharmalittle-we-re-reading-about-overton-fda-nomination-being-yanked-a.md)
- [Inferring tumor kinetics from single routine H&E biopsies to run virtual radiotherapy trials](https://medichelpline.com/clinical-feed/medrxiv-9-effective-tumor-kinetics-inferred-from-single-routine-h-e-biopsies-enable.md)
- [CXR and Bandim TBScore Weakly Predict Two‑Month Culture Conversion in PTB](https://medichelpline.com/clinical-feed/medrxiv-7-tuberculosis-severity-metrics-poorly-predict-two-month-culture-conversion.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.